Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Gabrielle Berns"'
Hybrid organic–inorganic perovskites (HOIPs) have emerged as an important class of materials because they exhibit many properties suitable for efficient energy conversion and storage. Although HOIPs have been the subject of many studies, the underl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ff0994b2cc946fddbfdaed559bde2472
https://doi.org/10.1016/b978-0-12-812915-9.00006-x
https://doi.org/10.1016/b978-0-12-812915-9.00006-x
Autor:
Javeed Akhtar, Muhammad Aamir, Diptonil Banerjee, Gabrielle Berns, Madhulika Bhati, Kalyan Kumar Chattopadhyay, Jayeeta Chattopadhyay, Abinash Das, Christie L.C. Ellis, Michael J. Heben, Hamza Javaid, Ramya Krishna, Suresh Maniarasu, Vishesh Manjunath, Balamurugan Manoharan, P. Mathan Kumar, Minu Mohan, Ranjith G. Nair, Tara Sankar Pathak, Adam B. Phillips, Radhika Rai, Vidya Raj, Easwaramoorthi Ramasamy, P.C. Reshmi Varma, Sarat Kumar Sahoo, Lalu Seban, Sakthivel Shanmugasundaram, Muhammad Sher, Narendiran Sivakumar, Emily Smith, Zhaoning Song, Ganapathy Veerappan, Dhandapani Venkataraman, Suneth C. Watthage
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e79c387bdb96f7e5de04e30b4e65b804
https://doi.org/10.1016/b978-0-12-812915-9.00022-8
https://doi.org/10.1016/b978-0-12-812915-9.00022-8
Autor:
Margarida Silverman, Praveen Vikas, Kalyan Nadiminti, Gabrielle Berns, Sarah L. Mott, Christopher Strouse, Michael Tomasson, Jillna Claus, Yogesh Jethava, Umar Farooq, Allyson Schultz
Publikováno v:
Biology of Blood and Marrow Transplantation. 25:S385-S386
Introduction While melphalan 200 mg/m2 has been the standard preparative regimen for ASCT, studies are currently evaluating the role of including novel agents along with melphalan to improve outcomes. We have previously reported outcomes in patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5ccd57d78e79ebf70e726c1ec9c19851
https://doi.org/10.1016/j.bbmt.2018.12.793
https://doi.org/10.1016/j.bbmt.2018.12.793
Autor:
Gabrielle Berns, Margarida Silverman, Sarah L. Mott, Lindsay Dozeman, Umar Farooq, Allyson Schultz, Fenghuang Zhan, Kalyan Nadiminti, Praveen Vikas, Christopher Strouse, Jillna Claus, Yogesh Jethava, Michael H. Tomasson
Publikováno v:
Blood. 132:2153-2153
Introduction : Melphalan 200mg/m2 has been the standard conditioning regimen for ASCT for multiple myeloma. Novel agents in combination with high dose melphan are being evaluated in clinical trials to improve outcomes. We previously reported results
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b1f41af68712875b42d7346861fa9db1
https://doi.org/10.1182/blood-2018-99-118443
https://doi.org/10.1182/blood-2018-99-118443